BPA is a global leading provider of innovative business software solutions based on Microsoft (MS) SharePoint technologies with 800+ customers and 50+ partners worldwide. Profitable since inception, BPA delivers business solutions, mobile solutions and cloud services that empower organizations to get closer relationships with their stakeholders, either internal or external. BPA’s out-of-the-box solutions, including BPA CRM, Quality, Risk, Recruiting and Self-Service are the next generation business solutions. All solutions are designed & directed to end users and work the way they work and not the other way around. Organizations get full control on their solutions and can deploy them as they want; on premise, in private or Microsoft clouds or in a hybrid environment.
“We are honored to welcome Debiopharm Investment to our team. Their long-term vision and human-centric approach fit perfectly to our vision & philosophy” said Dr. Boris Lutz, founder and CEO of BPA. Ms. Valérie Calvayrac, CEO of Debiopharm Investment, thinks that “BPA Solution has found its market in Switzerland and we are happy to support the Company in its new challenges and international development”.
“Our software products are now robust and mature. We have a unique selling proposal. It’s time for BPA to move from a R&D oriented company to a global marketing & sales oriented company. The new funding will enable BPA to accelerate its rapid growth, further expand internationally with a strong partner eco-system and keep developing innovative software solutions” said Mr. Lutz. Ms. Calvayrac adds “This spirit of continuous innovation is one of the main aspect that pleased us most, because it is completely in line with our own business philosophy”.
During the last three years BPA has been selected, as the unique non-North-American company, by Microsoft Corp in Redmond, US to participate in different exclusive programs such as the SharePoint Partner Advisory Board and the Technology Adoption Program for the new MS Office 365 version. The BPA development team had the chance to work hand in hand with Microsoft’s experts to develop an office 365 version of BPA CRM, as the first business application available for office 365. Additional solutions will be added in 2014.
“We have selected Microsoft SharePoint seven years ago as the technology platform for our solutions. That was the right choice. Microsoft SharePoint has become Microsoft’s most successful server product ever with hundreds of millions of users worldwide and it will keep growing with Office 365. says Boris Lutz. BPA is already in line with Microsoft’s recent reorientation towards devices and services, specifically for cloud services (Windows Azure and Office 365) and mobility (Tablets and phones). Microsoft’s decision to offer MS Office, its crown jewel, to iPhone, Android, Nokia and Blackberry users via its Office 365 Web Services is encouraging. Mobility is strategic to BPA’s growth such as cloud services and social media connectivity. A standalone BPA mobile solution for iPhone has just been released. iPad, Android and Windows mobile solutions will follow soon. Social media connectors such as LinkedIn and Xing are about to be released. BPA is devoted to improving the user experience and ease business relationships with its solutions.
In the coming months, BPA will consolidate its presence in North-America, Europe and Asia. BPA will invest in recruiting the best channel, hosting & technology partners. “There are plenty of exiting opportunities for partners today and for the next coming years” says Mr. Lutz. Ms. Calvayrac said: “As usual, we want to be a partner and an active member of the board, to help them accomplish this challenge successfully.” On this point, Boris Lutz concludes with humor “Valérie Calvayrac’s conclusion matches our BPA’s motto – better business through closer relationship – and we will prove it with Debiopharm”.
About BPA Solutions
BPA is a global leading provider of innovative business software solutions based on Microsoft SharePoint technologies with 800+ customers and 50+ partners worldwide. Profitable since inception, BPA delivers business solutions, mobile solutions and cloud services that empower organizations to get closer relationships with their stakeholders, either internal or external. Headquartered in Yverdon, Switzerland, BPA has offices in Leesburg, US and Kerala, IN. Please visit bpasolutions.wpengine.com for more information
About Debiopharm Investment
The mission of Debiopharm Investment is to diversify investments made by Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. This diversification occurs particularly with the Private Equity branch taking minority stakes in innovative IT, Cleantech and ‘Services for Individuals’ startups.
Debiopharm Investment SA Contact
Alexandra Le Coz Sanchez
Associate Director, Private Equity Manager
Tél.: +41 (0)21 321 01 11
BPA Solutions SA Contact
Dr Boris Lutz
Founder & CEO
Tél.: +41 (0)32 710 17 07